9823 Capital’s Lifestance Health LFST Stock Holding History

9823 Capital’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,910	Closed	-$178K	–	48
2026 Q1	$178K	Buy	+27,910	New	+$194K	0.13%	31

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

9823 Capital's LFST Position: Q2 2026 in Review

9823 Capital sold out of Lifestance Health (LFST) in Q2 2026, closing a stake of 27,910 shares — an estimated $178K sold.

9823 Capital first reported a position in LFST in Q1 2026 and held it in 1 quarter. The position peaked at $178K in Q1 2026. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

9823 Capital reported no remaining Lifestance Health position as of Q2 2026 after selling out during the quarter.
9823 Capital sold 27,910 Lifestance Health shares in Q2 2026, an estimated $178K.
9823 Capital first reported a position in Lifestance Health in Q1 2026 and held it in 1 quarter.
9823 Capital's Lifestance Health position peaked at $178K in Q1 2026.
287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on 9823 Capital's 13F filing for Q2 2026, filed 14 Aug 2026.